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S U M M A R Y 
The Authors studied the cell mediated immunity (CMI) and humoral antibody 
levels raised in response to canine antirabies vaccination and re vaccination. The 
vaccine used was the FUENZALIDA & PALACIOS which is routinelly utilized in 
human and canine vaccination in Brazil. The evaluation of CMI was done by inhi-
bition of peripheral leukocyte migration and antibody levels were measured by se-
rum neutralization and complement fixation tests. Five dogs were used and each 
animal received one daily dose of 1 ml of the vaccine for five days and one booster 
210 days after the initial schedule. All animals showed moderate antibody levels 
after the initial immunization and a clear secondary immune response following 
the booster dose. Cell mediated immune response however occurred only following 
the initial immunization and could not be detected after the booster dose. The 
Authors concluded that CMI occurred in canine antirabies primo-vaccination 
under the experimental conditions employed and that although a secondary cell 
mediated immune response was not detected in this study its existence cannot 
be rulled out but remains to be studied by means of other immunization expe-
riments. 
I N T R O D U C T I O N 
The protective role played by the different 
immunological mechanisms raised in responses 
to antirabies vaccine is still poorly understood. 
The most studied and still controvertial as-
pect is undoubtedly the antiviruses antibody 
level. In some situations, circulating anti-
bodies are clearly involved in protection5.7,8, 
however, natural infection may coexist with 
the presence of high levels of humoral anti-
bodies19 or on the other hand solid immunity 
may be seen in its absence » 9 . 
In experimental models, the administration 
of interferon or its production, induced by anti-
rabies and other antiviral vaccines or non bio-
logical inducers, proved to be protective if in-
terferon was present before or soon after the 
challenge. Despite of the fact that, commercial 
vaccines are not efficient inducers of interferon 
synthesis and also in practice, vaccination is 
usually done a few days after exposure, a solid 
protection is undoubtedly obtained. 
In spite of several previous suggestions on 
the role of cell mediated immunity mechanisms 
in antirabies protection, it was only in 1974 
that WIKTOR et al. showed the ability of 
rabies virus antigens to stimulate immunized 
rabbits lymphocytes in vitro. After that, RA-
MANNA 1 0 demonstrated that the citotoxicity 
mediated by immunized rabbits lymphocytes 
against BHK-21 cells infected by rabies viruses, 
preceded the detection of circulating anti-
bodies. 
In addition WIKTOR et al.1 8 showed that 
previous administration of antirabies anti-
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bodies to mice depresses both cell mediated 
immunity (CMI) and humoral immunity (HI) . 
More recently SANTOS et al.1 1 demonstrat-
ed the development of CMI in response to hu-
man antirabies vaccination. 
The purpose of this paper is the study of 
CMI and humoral antibody levels in dogs in 
response to antirabies vaccination and revac¬ 
cination. 
The choice of dogs as experimental animals 
is due to the fact that they are part of the epi-
demiological chain that leads to human rabies 
and are themselves subjected to the disease. 
The FUENZALIDA & PALACIOS vaccine« 
was used because it is the usual vaccine em-
ployed in human and canine antirabies vacci-
nation in Brazil; and the schedule was more 
intense than usual in order to obtain more evi-
dent and easily interpreted responses. 
MATERIALS AND METHODS 
1. ANIMALS — Five dogs from 6 to 48 
months old, without defined race and kept in in-
dividual cages during the study were used. Four 
of them (No. 1-4) were received at the age of 
2 months, born from non vaccinated mothers 
and kept in isolation before immunization. The 
last dog (No; 5) was sent to Instituto Pasteur 
de São Paulo for observation. No clinical signs 
of rabies were detected and according to its 
owner it had not been submitted to previous 
vaccination. 
2. VACCINATION SCHEDULE — For five 
days each animal received one daily dose of 
FUENZALIDA & PALACIOS vaccine and one 
booster 210 days after, by intra muscular route. 
Leukocytes from animals number 1 and 2 were 
used before immunization to check the antigen 
for mitogen or toxic activities in the leukocyte 
migration inhibition test (LIF). 
3. ANTIGENS — FUENZALIDA & PALA-
CIOS vaccine was used in the immunization and 
complement fixation reactions. Briefly, it con-
tains 2% of nervous tissue of newborn mice in-
fected with fixed rabies virus, PVI strain (sent 
to Instituto Butantãn by Instituto Pasteur de Pa-
ris in 1956), 0.5% of phenol and 1/10 000 of mer-
thiolate as preservatives and it is inactivated 
by ultra violet irradiation. The antigen used 
as control in complement fixation reactions 
consisted of a suspension of normal newborn 
mice nervous tissue prepared according to 
the technique used in the production of anti-
rabies vaccine. The antigen used in LIF was 
similar to the PUENZALIDA & PALACIOS vac-
cine except that it contains 10% of nervous tis-
sue and no preservatives. The control antigen 
was prepared with normal newborn mice ner-
vous tissue. 
4. BLOOD SAMPLING — Heparinized blood 
samples for LIF were collected asseptically by 
jugular puncture. Sera for complement fixation 
reactions (CF) and Serum neutralization test 
(SN) were obtained from blood samples colle-
tected without heparine and kept at -25°C. 
5. SN — the test was performed as describ-
ed by ATANASIU2, using the fixed virus CVS 
strain. 
6. CF — the reactions were performed ac-
cording to the technique described by ALMEI-
DA 1, adapted to the rabies system by PEREI¬ 
RA & PEREIRA 1 0, with the complement expres-
sed in 50% hemolytic units. 
7. LIF — the inhibition of peripheral blood 
leukocyte migration in the presence of proper 
antigen dilutions was performed according to 
the Soborg's technique with modifications11. 
Heparinized blood was collected under steriliz-
ed conditions. The buffy coat was separated 
and ajusted to 3xl07 cells/ml in Eagle's mini-
mal essential medium containing 10% of nor-
mal human serum (NHS). Polyethylene capilla-
ry tubes 7 cm long filled with the cell suspen-
sion were sealed at one end and centrifuged at 
150 g for 10 minutes. They were then cut at 
the cell-fluid interphase and placed in Sykes¬ 
Moore migration chambers. 
The chambers were filled with medium 
containing 10% NHS and the proper antigen 
(vaccine or tissue control antigen), in several 
concentrations. Each test was performed in 
duplicate. After an 18 hours incubation period 
at 37°C, the migration areas were measured 
using a screen microscope, and the migration 
index calculated as: 
mean area of migration with antigen 
mean area of migration without antigen 
Values of 0.75 or less were considered positive. 
RESULTS 
Results obtained after primo-vaccination in 
LIF, SN and CN reactions are presented in Ta-
ble I. From this data we can observe that all 
dogs showed a cell mediated immune respon­
se detected by LIF between the 8th and 15th 
day approximately. Antibodies were detectable 
in all immunized animals; one of them (No. 5) 
however, showed earlier synthesis and higher 
levels than the others. 
Data concerning to revaccination are shown 
in Table I I . No CMI was observed and antibody 
levels were higher than those obtained in the 
primo-vaccination. Dog No. 5 was the only 
one that still had high levels of antibodies at 
the time of booster. LIP and CP reactions 
with control antigens were always negative. 
DISCUSSION 
Our results show that antirabies vaccina­
tion of dogs induce specific cellular immunity 
in the experimental conditions employed. 
The results of LIP were positive for the 5 
dogs in a farily regular way, from the 8th 
to 15th days after the beginning of vaccination. 
Similar results were obtained with human 
beings 1 1 and guinea-pigs. Regarding to the pre­
sence of circulating antibodies, however, one 
of the dogs (No. 5) presented earlier detecta­
ble and higher levels than the others, that 
were still present at the time of booster. 
Cellular immune response was not observed 
after the booster on the 210th day of primo-
vaccination, although a clear secondary humo-
ral response was detected in all dogs. 
We could not rule out the possibility that 
dog No. 5 had been previously vaccinated, what 
would explain the higher humoral immune res-
ponse presented after our first immunization 
schedule. 
The absence of cellular immune response 
to revaccination may be explained by the find-
ings of WIKTOR et al. 1 7 in mice where a mi-
nor antigenic stimulus induced detectable anti-
bodies levels, but not CMI response. We must 
also have in mind the observations of WEBS-
T E E 1 6 in the thirties that small antigenic do-
ses induced antibody synthesis but protection 
was not obtained. 
The higher sensitivity of SN in the detec-
tion of antirabies antibodies in comparison to 
the CF tests in agreement with literature data 
on human beings 1 0. 
Although in our experimental conditions, 
we could be able to demonstrate CMI to anti-
rabies vaccination in dogs, a few questions 
remain to be clarified: 
What is the role played by CMI in protection? 
Can CMI be obtained in primo-vaccination 
with only one dose? 
Could a stronger antigenic stimulus give rise 
to CMI in revaccination? 
RESUMO 
Resposta imune celular na vacinação anti-rábica 
canina 
Os Autores estudaram a resposta imune ce-
lular e os níveis de anticorpos na vacinação e 
re-vacinação canina. A vacina utilizada foi a 
Fuenzalida & Palacios, empregada rotineira-
mente na imunização humana e canina, no Bra-
sil. A avaliação da resposta mediada por cé-
lulas foi feita por testes de inibição de migra-
ção de leucócitos periféricos. Os níveis de anti-
corpos foram determinados por provas de so-
ro-neutralização e fixação do complemento. Os 
cinco cães envolvidos no experimento recebe-
ram um esquema inicial de 5 doses e uma 
dose de reforço 210 dias após. Todos os ani-
mais exibiram níveis moderados de anticorpos 
após o esquema inicial e uma nítida resposta 
secundária após o reforço. A resposta imune ce-
lular, contudo, ocorreu apenas após a imuniza-
ção inicial, não sendo detectada em resposta à 
dose de reforço. 
Concluem os Autores que a resposta imu-
ne celular ocorre na primo-vacinação anti-rá-
bica canina nas condições experimentais em-
pregadas e que embora a resposta secundária 
não tenha sido obtida neste estudo sua exis-
tência não pode ser descartada e deve ser re-
estudada em outras condições. 
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